UroGen Pharma Ltd Stock Discussion

$UroGen Pharma Ltd (URGN.US)$
UroGen Announces Unprecedented 82.3% Duration of Response at 12 Months in the ENVISION Trial Investigating UGN-102 as Potentially the First FDA-Approved Non-Surgical Treatment for LG-IR-NMIBC
• Kaplan-Meier Estimate of Duration of Response at 12 Months in Patients Who Achieved a Complete Response at Three Months was 82.3% (95% CI, 75.9%, 87.1%)
• Side Effect Profile Consistent with Previous Clinical Trials of UGN-102
• UroGen will Host a Virt...

$United Therapeutics (UTHR.US)$  Phase 3
$Ironwood Pharmaceuticals (IRWD.US)$  Phase 3
$Liquidia (LQDA.US)$  Phase 3
$United Therapeutics (UTHR.US)$  Phase 3
$MorphoSys (MOR.US)$  Phase 3
$Immunocore (IMCR.US)$  Phase 3
$Crinetics (CRNX.US)$  Phase 3
$UroGen Pharma Ltd (URGN.US)$  Phase 3
$AstraZeneca (AZN.US)$  Phase 3
$AstraZeneca (AZN.US)$  Phase 3
$AstraZeneca (AZN.US)$  Phase 3
$AstraZeneca (AZN.US)$  Phase 3
$Capricor Therapeutics (CAPR.US)$  Phase 3
$Annexon (ANNX.US)$  Phase 3
$Lipocine (LPCN.US)$  Phase 3...

$Strong Global Entertainment (SGE.US)$ $UroGen Pharma Ltd (URGN.US)$ $The Real Good Food (RGF.US)$ $AltC Acquisition (ALCC.US)$ $Integrated Media Technology (IMTE.US)$ $Emergent BioSolutions (EBS.US)$
📊⚡️📊

$Travere Therapeutic (TVTX.US)$  Phase 3
$CG Oncology (CGON.US)$  Phase 3
$United Therapeutics (UTHR.US)$  Phase 3
$United Therapeutics (UTHR.US)$  Phase 3
$BioCardia (BCDA.US)$  Phase 3
$Insmed (INSM.US)$  Phase 3
$GlycoMimetics (GLYC.US)$  Phase 3
$Annexon (ANNX.US)$  Phase 3
$Lipocine (LPCN.US)$  Phase 3
$FibroGen (FGEN.US)$  Phase 3
$UroGen Pharma Ltd (URGN.US)$  Phase 3
$Lyra Therapeutics (LYRA.US)$  Phase 3
$Citius Pharmaceuticals (CTXR.US)$  Phase 3
$Jaguar Health (JAGX.US)$  Phas...

🎯 Ph 3 readouts in Q2 2024...
$Intra-Cellular Therapies (ITCI.US)$  Phase 3
$CG Oncology (CGON.US)$  Phase 3
$Hutchmed (China) (HCM.US)$  Phase 3
$Viracta Therapeutics (VIRX.US)$  Phase 3
$GlycoMimetics (GLYC.US)$  Phase 3
$Annexon (ANNX.US)$  Phase 3
$Lipocine (LPCN.US)$  Phase 3
$FibroGen (FGEN.US)$  Phase 3
$UroGen Pharma Ltd (URGN.US)$  Phase 3
$Lyra Therapeutics (LYRA.US)$  Phase 3
$Citius Pharmaceuticals (CTXR.US)$  Phase 3
$Marinus Pharmaceuticals (MRNS.US)$  Phase 3
$BioCardia (BCDA.US)$  Phase 3...